Your browser doesn't support javascript.
loading
Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors.
Chaudagar, Kiranj Kishor; Landon-Brace, Natalie; Solanki, Aniruddh; Hieromnimon, Hanna M; Hegermiller, Emma; Li, Wen; Shao, Yue; Joseph, John; Wilkins, Devan J; Bynoe, Kaela M; Li, Xiang-Ling; Clohessy, John G; Ullas, Soumya; Karp, Jeffrey M; Patnaik, Akash.
Afiliación
  • Chaudagar KK; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Landon-Brace N; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Solanki A; Harvard Stem Cell Institute, Harvard-MIT Division of Health Sciences and Technology, and the Broad Institute of Harvard and MIT, Boston, Massachusetts.
  • Hieromnimon HM; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Hegermiller E; Harvard Stem Cell Institute, Harvard-MIT Division of Health Sciences and Technology, and the Broad Institute of Harvard and MIT, Boston, Massachusetts.
  • Li W; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Shao Y; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Joseph J; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wilkins DJ; Harvard Stem Cell Institute, Harvard-MIT Division of Health Sciences and Technology, and the Broad Institute of Harvard and MIT, Boston, Massachusetts.
  • Bynoe KM; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Li XL; Harvard Stem Cell Institute, Harvard-MIT Division of Health Sciences and Technology, and the Broad Institute of Harvard and MIT, Boston, Massachusetts.
  • Clohessy JG; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ullas S; Harvard Stem Cell Institute, Harvard-MIT Division of Health Sciences and Technology, and the Broad Institute of Harvard and MIT, Boston, Massachusetts.
  • Karp JM; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Patnaik A; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Mol Cancer Ther ; 20(2): 438-449, 2021 02.
Article en En | MEDLINE | ID: mdl-33277441
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Piridinas / Proteínas Tirosina Quinasas Receptoras / Nanopartículas / Anilidas / Neutrófilos Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Piridinas / Proteínas Tirosina Quinasas Receptoras / Nanopartículas / Anilidas / Neutrófilos Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article